Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY) safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM (TWICE-WEEKLY).ESTRADIOL transdermal system, USP (TWICE-WEEKLY)Initial U.S. Approval: 1996
Medication labelWhy this: Advisory · dailymed-prescription
Estradiol transdermal system, USP (twice-weekly) is indicated for: Limitations of Use: When prescribing solely for the treatment of moderate to severe symptoms of vulvar and vaginal atrophy, first consider the use of topical vaginal products. Limitations of Use: When prescribing solely for the prevention of postmenopausal osteoporosis, first consider the use of non-estrogen medications. Consider estrogen therapy only for women at significant risk of osteoporosis.
- generic_name
- estradiol
- product_names
- Estradiol
- ndc
- 70710-1191, 70710-1192, 70710-1193, 70710-1194, 70710-1195, 70710-1191-1, 70710-1191-8, 70710-1192-1, 70710-1192-8, 70710-1193-1, 70710-1193-8, 70710-1194-1, 70710-1194-8, 70710-1195-1, 70710-1195-8
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en